Pre-transplant screening for coronary artery disease: data are required before practice change.
Declining rates of peri-transplant cardiovascular death, an increasing burden of pre-transplant tests and concerns over the effectiveness of screening candidates for coronary artery disease have led many transplant programs to de-escalate screening protocols. Recent KDIGO and American Heart Association scientific statements and guidelines neatly summarize current evidence, but also identify areas of need. Here, we argue that key questions should be addressed by adequately powered clinical trials before our long-held screening paradigms are completely re-written.
Source: Kidney International - Category: Urology & Nephrology Authors: John S. Gill, Steven J. Chadban, John S. Gill Tags: mini review Source Type: research
More News: Cardiology | Cardiovascular | Clinical Trials | Heart | Heart Transplant | Kidney Transplant | Kidney Transplantation | Transplant Surgery | Transplants | Urology & Nephrology